secwatch.observer — SEC 8-K summary
======================================

Issuer:     AGILE THERAPEUTICS INC (—)
CIK:        0001261249
Form:       8-K/A
Filed at:   2023-08-22T23:59:59+00:00
Accession:  0001558370-23-015153
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Agile Therapeutics appoints Scott Coiante as CFO; discloses employment terms and CAO departure
--------------------------------------------------------------------------------

- Scott Coiante appointed SVP, CFO & Treasurer effective Aug 16, 2023; base salary $430K, target bonus 45%.
- Coiante receives inducement grant of 20,000 RSUs vesting over 4 years; acceleration upon change of control.
- Severance: 12 months base salary (non-CoC) or 18 months lump sum plus bonus and equity acceleration (CoC).
- Jason Butch separated as CAO effective Aug 15, 2023; receives 6 months base salary and benefits.
- Coiante subject to 18-month non-compete and perpetual confidentiality covenants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1261249/000155837023015153/0001558370-23-015153-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1261249/000155837023015153/agrx-20230621x8ka.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-015153

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer